J&J CEO Gorsky on M&A, Health Care, Tax Reform

The transcript covers Johnson & Johnson's strategic acquisition of Actelion, emphasizing the importance of cultural integration in mergers. It discusses the company's diversified model, pharmaceutical innovations, and challenges in the healthcare industry. The impact of tax reform on global competitiveness and labor market conditions are also explored, along with J&J's commitment to environmental sustainability.

How does Johnson & Johnson view the future of its Remicade product in light of competition from biosimilars?

What are the anticipated impacts of tax reform on Johnson & Johnson's capital allocation strategy?

What strategies does Johnson & Johnson employ to attract and retain top talent in a competitive labor market?

In what ways does Johnson & Johnson plan to contribute to environmental sustainability?